| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99241 |
|
2,906 |
1,938 |
$283K |
| 99242 |
|
534 |
391 |
$79K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,126 |
675 |
$21K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
159 |
158 |
$16K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,253 |
872 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
406 |
312 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,685 |
1,086 |
$4K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,009 |
662 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
937 |
688 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
307 |
223 |
$934.18 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
226 |
170 |
$633.05 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
198 |
110 |
$272.69 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
31 |
18 |
$62.60 |
| 87807 |
|
13 |
13 |
$10.06 |
| 81003 |
|
24 |
12 |
$4.36 |
| 99201 |
|
12 |
12 |
$0.00 |